Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
This report aims to provide a comprehensive study of the global market for Lanreotide Injection. Report Highlights:
(1) Global Lanreotide Injection market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Lanreotide Injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Lanreotide Injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Lanreotide Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Lanreotide Injection segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Lanreotide Injection, capacity, production and trends.
(7) Lanreotide Injection industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Lanreotide Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Lanreotide Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Lanreotide Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Sustained Release Formulation segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Lanreotide Injection include Ipsen and Cipla etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Sustained Release Formulation
Long-acting Formula
Market segment by application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Ipsen
Cipla
1 Market Overview
1.1 Lanreotide Injection Definition
1.2 Global Lanreotide Injection Market Size and Forecast
1.2.1 By Revenue, Global Lanreotide Injection Market Size, 2018-2029
1.2.2 By Sales Volume, Global Lanreotide Injection Market Size, 2018-2029
1.2.3 Global Lanreotide Injection Price Trend, 2018-2029
1.3 China Lanreotide Injection Market Size and Forecast
1.3.1 By Revenue, China Lanreotide Injection Market Size, 2018-2029
1.3.2 By Sales Volume, China Lanreotide Injection Market Size, 2018-2029
1.3.3 China Lanreotide Injection Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Lanreotide Injection Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Lanreotide Injection Share in Global Market, 2018-2029
1.4.3 Lanreotide Injection Market Size: China VS Global, 2018-2029
1.5 Lanreotide Injection Market Dynamics
1.5.1 Lanreotide Injection Market Drivers
1.5.2 Lanreotide Injection Market Restraints
1.5.3 Lanreotide Injection Industry Trends
1.5.4 Lanreotide Injection Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Lanreotide Injection Revenue by Company, 2018-2023
2.2 Global Lanreotide Injection Sales Volume by Company, 2018-2023
2.3 Global Lanreotide Injection Price by Company, 2018-2023
2.4 Global Lanreotide Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Lanreotide Injection Concentration Ratio
2.6 Global Lanreotide Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Lanreotide Injection Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Lanreotide Injection Revenue by Company, 2018-2023
3.2 China Lanreotide Injection Sales Volume by Company, 2018-2023
3.3 China Lanreotide Injection Lanreotide Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Lanreotide Injection Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Lanreotide Injection Domestic VS Export
3.6 China Market, Lanreotide Injection Import & Export
3.6.1 China Market, Lanreotide Injection Import & Export, 2018-2029
3.6.2 China Lanreotide Injection Import & Export Trends
3.6.3 Main Sources of China Lanreotide Injection Import
3.6.4 Export Destination of China Lanreotide Injection
4 Lanreotide Injection Production by Region
4.1 Global Lanreotide Injection Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Lanreotide Injection Manufacturers
4.3 Global Major Manufacturers, Lanreotide Injection Capacity Expansion and Future Plans
4.4 Global Lanreotide Injection Capacity by Region
4.5 Global Lanreotide Injection Production by Region
4.5.1 Global Lanreotide Injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Lanreotide Injection Production by Region, 2018-2023
4.5.3 Global Lanreotide Injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lanreotide Injection Industry Chain
5.2 Lanreotide Injection Upstream Analysis
5.2.1 Lanreotide Injection Core Raw Materials
5.2.2 Main Manufacturers of Lanreotide Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lanreotide Injection Production Mode
5.6 Lanreotide Injection Procurement Model
5.7 Lanreotide Injection Industry Sales Model and Sales Channels
5.7.1 Lanreotide Injection Sales Model
5.7.2 Lanreotide Injection Typical Distributors
6 Sights by Type
6.1 Lanreotide Injection Classification
6.1.1 Sustained Release Formulation
6.1.2 Long-acting Formula
6.2 By Type, Global Lanreotide Injection Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lanreotide Injection Revenue, 2018-2029
6.4 By Type, Global Lanreotide Injection Sales Volume, 2018-2029
6.5 By Type, Global Lanreotide Injection Price, 2018-2029
7 Sights by Application
7.1 Lanreotide Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Lanreotide Injection Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lanreotide Injection Revenue, 2018-2029
7.4 By Application, Global Lanreotide Injection Sales Volume, 2018-2029
7.5 By Application, Global Lanreotide Injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lanreotide Injection Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Lanreotide Injection Revenue, 2018-2029
8.3 By Region, Global Lanreotide Injection Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Lanreotide Injection Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Lanreotide Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Lanreotide Injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lanreotide Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lanreotide Injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lanreotide Injection Market Size Market Share
8.7 South America
8.7.1 South America Lanreotide Injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lanreotide Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lanreotide Injection Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Lanreotide Injection Revenue, 2018-2029
9.3 By Country, Global Lanreotide Injection Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Lanreotide Injection Market Size, 2018-2029
9.4.2 By Company, U.S. Lanreotide Injection Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Lanreotide Injection Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Lanreotide Injection Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lanreotide Injection Market Size, 2018-2029
9.5.2 By Company, Europe Lanreotide Injection Sales Volume Market Share, 2022
9.5.3 By Type, Europe Lanreotide Injection Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Lanreotide Injection Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Lanreotide Injection Market Size, 2018-2029
9.6.2 By Company, China Lanreotide Injection Sales Volume Market Share, 2022
9.6.3 By Type, China Lanreotide Injection Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Lanreotide Injection Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lanreotide Injection Market Size, 2018-2029
9.7.2 By Company, Japan Lanreotide Injection Sales Volume Market Share, 2022
9.7.3 By Type, Japan Lanreotide Injection Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Lanreotide Injection Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lanreotide Injection Market Size, 2018-2029
9.8.2 By Company, South Korea Lanreotide Injection Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Lanreotide Injection Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Lanreotide Injection Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lanreotide Injection Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Lanreotide Injection Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Lanreotide Injection Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Lanreotide Injection Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Lanreotide Injection Market Size, 2018-2029
9.10.2 By Company, India Lanreotide Injection Sales Volume Market Share, 2022
9.10.3 By Type, India Lanreotide Injection Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Lanreotide Injection Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Lanreotide Injection Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Lanreotide Injection Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Lanreotide Injection Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Lanreotide Injection Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ipsen
10.1.1 Ipsen Company Information, Head Office, Market Area and Industry Position
10.1.2 Ipsen Lanreotide Injection Models, Specifications and Application
10.1.3 Ipsen Lanreotide Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ipsen Company Profile and Main Business
10.1.5 Ipsen Recent Developments
10.2 Cipla
10.2.1 Cipla Company Information, Head Office, Market Area and Industry Position
10.2.2 Cipla Lanreotide Injection Models, Specifications and Application
10.2.3 Cipla Lanreotide Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Cipla Company Profile and Main Business
10.2.5 Cipla Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Lanreotide Injection Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lanreotide Injection Market Restraints
Table 3. Lanreotide Injection Market Trends
Table 4. Lanreotide Injection Industry Policy
Table 5. Global Lanreotide Injection Revenue by Company, 2018-2023, US$ million
Table 6. Global Lanreotide Injection Revenue Market Share by Company, 2018-2023
Table 7. Global Lanreotide Injection Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Lanreotide Injection Sales Volume Market Share by Company, 2018-2023
Table 9. Global Lanreotide Injection Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Lanreotide Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lanreotide Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Lanreotide Injection Manufacturers Product Type
Table 13. China Lanreotide Injection Revenue by Company, 2018-2023, US$ million
Table 14. China Lanreotide Injection Revenue Market Share by Company, 2018-2023
Table 15. China Lanreotide Injection Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Lanreotide Injection Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Lanreotide Injection Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Lanreotide Injection Import & Export Trends
Table 19. Main Sources of China Lanreotide Injection Import
Table 20. Export Destination of China Lanreotide Injection
Table 21. Global Headquarters and Manufacturing Base of Lanreotide Injection Manufacturers
Table 22. Global Major Manufacturers, Lanreotide Injection Capacity Expansion and Future Plans
Table 23. Global Lanreotide Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Lanreotide Injection Production by Region, 2018-2023, (K Units)
Table 25. Global Lanreotide Injection Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Lanreotide Injection Upstream (Raw Materials)
Table 27. Global Lanreotide Injection Typical Customers
Table 28. Lanreotide Injection Typical Distributors
Table 29. By Type, Global Lanreotide Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Lanreotide Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Lanreotide Injection Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Lanreotide Injection Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Lanreotide Injection Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Lanreotide Injection Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Lanreotide Injection Revenue Market Share, 2018-2029
Table 37. By Country, Global Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Lanreotide Injection Sales Volume Market Share, 2018-2029
Table 39. Ipsen Company Information, Head Office, Market Area and Industry Position
Table 40. Ipsen Lanreotide Injection Models, Specifications and Application
Table 41. Ipsen Lanreotide Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Ipsen Company Profile and Main Business
Table 43. Ipsen Recent Developments
Table 44. Cipla Company Information, Head Office, Market Area and Industry Position
Table 45. Cipla Lanreotide Injection Models, Specifications and Application
Table 46. Cipla Lanreotide Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cipla Company Profile and Main Business
Table 48. Cipla Recent Developments
List of Figure
Figure 1. Lanreotide Injection Picture
Figure 2. By Revenue, Global Lanreotide Injection Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Lanreotide Injection Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Lanreotide Injection Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Lanreotide Injection Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Lanreotide Injection Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Lanreotide Injection Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Lanreotide Injection Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Lanreotide Injection Share of Global Market, 2018-2029
Figure 10. Global Lanreotide Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Lanreotide Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Lanreotide Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Lanreotide Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Lanreotide Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Lanreotide Injection Domestic VS Export, 2022
Figure 16. Global Lanreotide Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Lanreotide Injection Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Lanreotide Injection Production Market Share & Forecast by Region, 2018-2029
Figure 19. Lanreotide Injection Industry Chain
Figure 20. Lanreotide Injection Procurement Model
Figure 21. Lanreotide Injection Sales Model
Figure 22. Lanreotide Injection Sales Channels, Direct Sales and Distribution
Figure 23. Sustained Release Formulation
Figure 24. Long-acting Formula
Figure 25. By Type, Global Lanreotide Injection Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Lanreotide Injection Revenue Market Share, 2018-2029
Figure 27. By Type, Global Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Lanreotide Injection Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Lanreotide Injection Price, 2018-2029, (US$/Unit)
Figure 30. Hospital
Figure 31. Clinic
Figure 32. Others
Figure 33. By Application, Global Lanreotide Injection Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Lanreotide Injection Revenue Market Share, 2018-2029
Figure 35. By Application, Global Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Lanreotide Injection Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Lanreotide Injection Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Lanreotide Injection Revenue Market Share, 2018-2029
Figure 39. By Region, Global Lanreotide Injection Sales Volume Market Share, 2018-2029
Figure 40. North America Lanreotide Injection Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Lanreotide Injection Revenue Market Share, 2022
Figure 42. Europe Lanreotide Injection Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Lanreotide Injection Revenue Market Share, 2022
Figure 44. Asia Pacific Lanreotide Injection Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Lanreotide Injection Revenue Market Share, 2022
Figure 46. South America Lanreotide Injection Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Lanreotide Injection Revenue Market Share, 2022
Figure 48. Middle East & Africa Lanreotide Injection Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 50. By Company, U.S. Lanreotide Injection Market Share, 2022
Figure 51. By Type, U.S. Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, Europe Lanreotide Injection Market Share, 2022
Figure 55. By Type, Europe Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 57. China Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, China Lanreotide Injection Market Share, 2022
Figure 59. By Type, China Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, Japan Lanreotide Injection Market Share, 2022
Figure 63. By Type, Japan Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, South Korea Lanreotide Injection Market Share, 2022
Figure 67. By Type, South Korea Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, Southeast Asia Lanreotide Injection Market Share, 2022
Figure 71. By Type, Southeast Asia Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 73. India Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, India Lanreotide Injection Market Share, 2022
Figure 75. By Type, India Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Lanreotide Injection Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, Middle East & Asia Lanreotide Injection Market Share, 2022
Figure 79. By Type, Middle East & Asia Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Lanreotide Injection Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Reason to Buy